TD Private Client Wealth’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-103
Closed -$796 1722
2025
Q3
$796 Buy
+103
New +$804 ﹤0.01% 1375
2024
Q2
Sell
-212
Closed -$3.2K 1261
2024
Q1
$3.2K Hold
212
﹤0.01% 1111
2023
Q4
$4.57K Sell
212
-104
-33% -$1.92K ﹤0.01% 1121
2023
Q3
$5.87K Sell
316
-40
-11% -$934 ﹤0.01% 1098
2023
Q2
$9.01K Hold
356
﹤0.01% 1068
2023
Q1
$9.22K Hold
356
﹤0.01% 1047
2022
Q4
$8.42K Sell
356
-43
-11% -$1.16K ﹤0.01% 1033
2022
Q3
$10.1K Buy
399
+90
+29% +$3.16K ﹤0.01% 994
2022
Q2
$10.3K Buy
309
+111
+56% +$4.71K ﹤0.01% 1000
2022
Q1
$14.3K Buy
198
+80
+68% +$5.76K ﹤0.01% 998
2021
Q4
$10.8K Hold
118
﹤0.01% 908
2021
Q3
$15K Hold
118
﹤0.01% 877
2021
Q2
$19.6K Sell
118
-11
-9% -$1.78K ﹤0.01% 853
2021
Q1
$23.4K Sell
129
-2,753
-96% -$639K ﹤0.01% 808
2020
Q4
$576K Buy
2,882
+2,225
+339% +$452K 0.03% 362
2020
Q3
$144K Buy
+657
New +$139K 0.01% 491

Other funds holding TDOC

TD Private Client Wealth's TDOC Position: Q4 2025 in Review

TD Private Client Wealth sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 103 shares — an estimated $796 sold.

TD Private Client Wealth first reported a position in TDOC in Q3 2020 and held it in 16 quarters. The position peaked at $576K in Q4 2020. 344 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • TD Private Client Wealth reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • TD Private Client Wealth sold 103 Teladoc Health shares in Q4 2025, an estimated $796.
  • TD Private Client Wealth first reported a position in Teladoc Health in Q3 2020 and held it in 16 quarters.
  • TD Private Client Wealth's Teladoc Health position peaked at $576K in Q4 2020.
  • 344 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on TD Private Client Wealth's 13F filing for Q4 2025, filed 5 Feb 2026.